Lysander-Patient Capital Equity Fund – Series A
- Fund Code: LYZ905A
- Portfolio Manager: Patient Capital Management
- As of: April 30, 2023
- Asset Class: Equity
- CIFSC Category: Global Equity
- Benchmark: S&P/TSX Composite Total Return Index1
A global equity fund that invests in a diversified portfolio consisting primarily of global equity securities.
Why Invest in this Fund?
Established in 2000, Patient Capital Management is an independent firm with a highly disciplined and focused investment strategy anchored in Absolute Value. The sole purpose of Patient Capital Management is to preserve and grow the wealth of investors through the implementation of a long term investment strategy focusing on the purchase of high quality businesses at a substantial discount to their intrinsic value. When fully invested the portfolio will hold approximately twenty to twenty five securities in order to maximize the return potential of each security selection. The fund will look very different from equity indexes.
|Inception Date||December 30, 2014|
|Fund AUM||$11.2 Million|
|MER as of December 31, 2022||2.13%|
|Minimum Initial Investment||$500|
|Minimum Subsequent Investment||$100|
Compound Returns – Series A
|1 Month||3 Months||YTD||1 Year||3 Year
Calendar Year Returns – Series A
Top 10 Holdings
|Security||% of Fund|
|Canada T-Bill Due June 22/23||52.1%|
|Verizon Communications Inc.||5.3%|
|Honda Motor Co. Ltd. ADR||5.0%|
|Bank of Nova Scotia||4.8%|
|Canadian Imperial Bank of Commerce||4.7%|
|Canadian Natural Resources||3.4%|
|Cdn. Utilities Ltd.||3.4%|
|Number of Securities||16|
|Dividend Yield (%)||4.5%|
- Distribution Frequency: Quarterly
- Most Recent Distribution per Unit: $0.0575
- 12-Month Trailing Distribution Yield: 1.3%
- Next Record Date: June 29, 2023
- Next Distribution Date: June 30, 2023
Lysander Funds Limited is the investment fund manager of Lysander Patient Capital Equity Fund (the “Fund”). This document is not an invitation to invest in the Fund and does not constitute a public offering of sale. Purchases in the Fund can only be made through an Investment Professional on the terms in the Fund’s offering document by eligible investors. Each purchaser of units in a fund may have statutory or contractual right of action. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed or insured, their values change frequently and past performance may not be repeated. 1Source: TSX © Copyright 2023 TSX Inc. All Rights Reserved. 2Distributions are based on the actual number of units outstanding at the relevant time. Distributions are paid in cash or reinvested in additional units. If the series’ net income/capital gains is less than the amounts distributed in the year, the distribution will include a return of capital. In these circumstances, if an investor elects to receive their distributions in cash and not reinvest distributions, it is expected that the value of their investment will decline over time. Distributions are not an indication of performance, rate of return or yield. On November 1, 2021, the portfolio manager of the fund changed from 18 Asset Management Inc. to Patient Capital Management Inc. and the investment objective of the fund no longer had a Canadian equity securities focus. These changes could have affected the performance of the fund had these changes been in effect throughout the performance measurement period.
®Lysander Funds is a registered trademark of Lysander Funds Limited.
Toll Free: (877) 308-6979 Website: www.lysanderfunds.com